US3797494A
(en)
*
|
1969-04-01 |
1974-03-19 |
Alza Corp |
Bandage for the administration of drug by controlled metering through microporous materials
|
US3993073A
(en)
*
|
1969-04-01 |
1976-11-23 |
Alza Corporation |
Novel drug delivery device
|
US3854480A
(en)
*
|
1969-04-01 |
1974-12-17 |
Alza Corp |
Drug-delivery system
|
US3896819A
(en)
*
|
1969-04-01 |
1975-07-29 |
Alejandro Zaffaroni |
IUD having a replenishing drug reservoir
|
US3710795A
(en)
*
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
US3964482A
(en)
*
|
1971-05-17 |
1976-06-22 |
Alza Corporation |
Drug delivery device
|
US3731683A
(en)
*
|
1971-06-04 |
1973-05-08 |
Alza Corp |
Bandage for the controlled metering of topical drugs to the skin
|
US3742951A
(en)
*
|
1971-08-09 |
1973-07-03 |
Alza Corp |
Bandage for controlled release of vasodilators
|
US3996934A
(en)
*
|
1971-08-09 |
1976-12-14 |
Alza Corporation |
Medical bandage
|
US3993071A
(en)
*
|
1971-09-09 |
1976-11-23 |
Alza Corporation |
Bioerodible ocular device
|
US3960150A
(en)
*
|
1971-09-09 |
1976-06-01 |
Alza Corporation |
Bioerodible ocular device
|
US3986510A
(en)
*
|
1971-09-09 |
1976-10-19 |
Alza Corporation |
Bioerodible ocular device
|
US3981303A
(en)
*
|
1971-09-09 |
1976-09-21 |
Alza Corporation |
Bioerodible ocular device
|
US3807398A
(en)
*
|
1972-09-19 |
1974-04-30 |
B Grucza |
Ocular implant
|
US3961628A
(en)
*
|
1974-04-10 |
1976-06-08 |
Alza Corporation |
Ocular drug dispensing system
|
US3993072A
(en)
*
|
1974-08-28 |
1976-11-23 |
Alza Corporation |
Microporous drug delivery device
|
US3951622A
(en)
*
|
1974-12-04 |
1976-04-20 |
Wilk Immanuel J |
Time release perfume method and device
|
DE2647581A1
(en)
*
|
1976-10-21 |
1978-04-27 |
Henkel Kgaa |
BLISTER PACK
|
DE2650306A1
(en)
*
|
1976-11-02 |
1978-05-03 |
Merck Patent Gmbh |
ANTIBACTERIAL DRESSING AND METHOD OF ITS MANUFACTURING
|
US4201211A
(en)
*
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
US4286592A
(en)
*
|
1980-02-04 |
1981-09-01 |
Alza Corporation |
Therapeutic system for administering drugs to the skin
|
US4336243A
(en)
*
|
1980-08-11 |
1982-06-22 |
G. D. Searle & Co. |
Transdermal nitroglycerin pad
|
US5286748A
(en)
*
|
1981-01-05 |
1994-02-15 |
Eby Iii George A |
General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
|
EP0065370B1
(en)
*
|
1981-05-02 |
1985-01-23 |
Smith and Nephew Associated Companies p.l.c. |
Sterile dressing and preparation thereof
|
US4834979A
(en)
*
|
1981-06-29 |
1989-05-30 |
Alza Corporation |
Medical bandage for administering beneficial drug
|
US4725272A
(en)
*
|
1981-06-29 |
1988-02-16 |
Alza Corporation |
Novel bandage for administering beneficial drug
|
US4460371A
(en)
*
|
1981-11-24 |
1984-07-17 |
Dennison Manufacturing Company |
Silicone pressure sensitive adhesive and uses
|
US4925671A
(en)
*
|
1981-11-24 |
1990-05-15 |
Flexcon Company, Inc. |
Silicone pressure sensitive adhesive and uses
|
US4435180A
(en)
|
1982-05-25 |
1984-03-06 |
Alza Corporation |
Elastomeric active agent delivery system and method of use
|
IN157223B
(en)
*
|
1982-07-16 |
1986-02-15 |
Central Wechsel Creditbank |
|
JPS5948409A
(en)
*
|
1982-09-10 |
1984-03-19 |
Teikoku Seiyaku Kk |
Promotor for orthodontic tooth mobility
|
US4608249A
(en)
*
|
1982-11-02 |
1986-08-26 |
Nitto Electric Industrial Co., Ltd. |
Hydrophilic therapeutic material
|
DE3315272C2
(en)
*
|
1983-04-27 |
1986-03-27 |
Lohmann Gmbh & Co Kg, 5450 Neuwied |
Pharmaceutical product and process for its manufacture
|
US4563184A
(en)
*
|
1983-10-17 |
1986-01-07 |
Bernard Korol |
Synthetic resin wound dressing and method of treatment using same
|
EP0163696B1
(en)
*
|
1983-11-14 |
1992-11-25 |
Columbia Laboratories, Inc. |
Use of a bioadhesive
|
US4795436A
(en)
*
|
1983-11-14 |
1989-01-03 |
Bio-Mimetics, Inc. |
Bioadhesive composition and method of treatment therewith
|
US5364628A
(en)
*
|
1985-05-31 |
1994-11-15 |
Sandoz Ltd. |
Pharmaceutical compositions
|
EP0156080B2
(en)
*
|
1984-03-05 |
1993-10-20 |
Nitto Denko Corporation |
Percutaneous absorption type adhesive pharmaceutical preparation
|
FR2562800A1
(en)
*
|
1984-04-11 |
1985-10-18 |
Fournier Laboratoires |
Device for percutaneous administration of medicaments
|
US4725439A
(en)
*
|
1984-06-29 |
1988-02-16 |
Alza Corporation |
Transdermal drug delivery device
|
US4704282A
(en)
*
|
1984-06-29 |
1987-11-03 |
Alza Corporation |
Transdermal therapeutic system having improved delivery characteristics
|
EP0186660A4
(en)
*
|
1984-07-07 |
1987-01-22 |
Flexcon Co Inc |
Silicone pressure sensitive adhesive and uses.
|
US4649075A
(en)
*
|
1984-08-09 |
1987-03-10 |
Leonora Jost |
Transdermal and transmucosal vortexed foam devices and the method of making
|
US4568343A
(en)
*
|
1984-10-09 |
1986-02-04 |
Alza Corporation |
Skin permeation enhancer compositions
|
US4751133A
(en)
*
|
1984-11-13 |
1988-06-14 |
Thermedics, Inc. |
Medical patches and processes for producing same
|
US4638043A
(en)
*
|
1984-11-13 |
1987-01-20 |
Thermedics, Inc. |
Drug release system
|
US4880690A
(en)
*
|
1984-11-13 |
1989-11-14 |
Thermedics, Inc. |
Perfume patch
|
US4727868A
(en)
*
|
1984-11-13 |
1988-03-01 |
Thermedics, Inc. |
Anisotropic wound dressing
|
USRE32991E
(en)
*
|
1984-11-13 |
1989-07-18 |
Thermedics, Inc. |
Drug dispensing wound dressing
|
US4614787A
(en)
*
|
1984-11-13 |
1986-09-30 |
Thermedics, Inc. |
Drug dispensing wound dressing
|
US4752478A
(en)
*
|
1984-12-17 |
1988-06-21 |
Merck & Co., Inc. |
Transdermal system for timolol
|
US4597961A
(en)
*
|
1985-01-23 |
1986-07-01 |
Etscorn Frank T |
Transcutaneous application of nicotine
|
JPS61280426A
(en)
*
|
1985-06-04 |
1986-12-11 |
Ikeda Mohandou:Kk |
Anti-inflammatory and analgesic application agent
|
EP0252076A1
(en)
*
|
1985-12-12 |
1988-01-13 |
Flexcon Company, Inc. |
Transdermal methods and adhesives
|
US4666441A
(en)
*
|
1985-12-17 |
1987-05-19 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patches
|
US5204339A
(en)
*
|
1986-01-31 |
1993-04-20 |
Whitby Research, Inc. |
Penetration enhancers for transdermal delivery of systemic agents
|
WO1987004594A1
(en)
*
|
1986-01-31 |
1987-08-13 |
Nelson Research And Development Company |
Compositions comprising 1-substituted azacycloalkanes and their uses
|
US4764378A
(en)
*
|
1986-02-10 |
1988-08-16 |
Zetachron, Inc. |
Buccal drug dosage form
|
US4743249A
(en)
*
|
1986-02-14 |
1988-05-10 |
Ciba-Geigy Corp. |
Dermal and transdermal patches having a discontinuous pattern adhesive layer
|
DE3770836D1
(en)
*
|
1986-02-14 |
1991-07-25 |
Ciba Geigy Ag |
DERMAL AND TRANSDERMAL THERAPEUTIC SYSTEMS WITH PATTERN-BASED ADHESIVE LAYER, AND METHOD FOR THE PRODUCTION THEREOF.
|
US4797284A
(en)
*
|
1986-03-12 |
1989-01-10 |
Merck & Co., Inc. |
Transdermal drug delivery system
|
US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
CA1272922A
(en)
*
|
1986-06-03 |
1990-08-21 |
Peter William Berry |
Drug delivery device, its preparation and use
|
EP0249343B1
(en)
*
|
1986-06-13 |
1992-01-08 |
Alza Corporation |
Moisture activation of transdermal drug delivery system
|
EP0249475A3
(en)
*
|
1986-06-13 |
1989-10-11 |
Alza Corporation |
Delayed percutaneous delivery
|
EP0258521B1
(en)
*
|
1986-08-23 |
1990-05-02 |
Arno Walter Latzke |
Means for applying media by percutany
|
USRE37934E1
(en)
|
1986-08-28 |
2002-12-10 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system
|
US5820876A
(en)
*
|
1986-08-28 |
1998-10-13 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system
|
US6126963A
(en)
*
|
1986-08-28 |
2000-10-03 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
US6139868A
(en)
*
|
1986-08-28 |
2000-10-31 |
Lts Lohmann Therapie-Systeme Gmbh & Co. Kg |
Transdermal therapeutic system, its use and production process
|
JPH0794384B2
(en)
*
|
1986-09-01 |
1995-10-11 |
帝国製薬株式会社 |
Sustained-release oral formulation
|
US5196202A
(en)
*
|
1986-09-01 |
1993-03-23 |
Teikoku Seiyaku Kabushiki Kaisha |
Sustained release dosage form
|
US4938759A
(en)
|
1986-09-02 |
1990-07-03 |
Alza Corporation |
Transdermal delivery device having a rate controlling adhesive
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
CH672888A5
(en)
*
|
1986-11-07 |
1990-01-15 |
Mepha Ag |
|
IL84498A0
(en)
*
|
1986-11-20 |
1988-04-29 |
Ciba Geigy Ag |
User-activated transdermal therapeutic system
|
FR2607003B1
(en)
*
|
1986-11-20 |
1993-01-15 |
Marchandise Jean |
HOMEOPATHIC SKIN CARD
|
US4909244B1
(en)
*
|
1986-11-26 |
1994-07-05 |
Kendall & Co |
Hydrogel wound dressing
|
US5322695A
(en)
*
|
1987-01-09 |
1994-06-21 |
Hercon Laboratories Corporation |
Moisture-vapor-permeable dressing
|
US4917688A
(en)
*
|
1987-01-14 |
1990-04-17 |
Nelson Research & Development Co. |
Bandage for transdermal delivery of systemically-active drug
|
US4940586A
(en)
*
|
1987-02-26 |
1990-07-10 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4816258A
(en)
*
|
1987-02-26 |
1989-03-28 |
Alza Corporation |
Transdermal contraceptive formulations
|
US4900555A
(en)
*
|
1987-02-26 |
1990-02-13 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4788062A
(en)
*
|
1987-02-26 |
1988-11-29 |
Alza Corporation |
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
|
US4865848A
(en)
*
|
1987-02-26 |
1989-09-12 |
Alza Corporation |
Skin permeation enhancer compositions using sucrose esters
|
US4746515A
(en)
*
|
1987-02-26 |
1988-05-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolaurate
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5000956A
(en)
*
|
1987-03-09 |
1991-03-19 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5118509A
(en)
*
|
1987-03-09 |
1992-06-02 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
US5077054A
(en)
*
|
1987-03-09 |
1991-12-31 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5171576A
(en)
*
|
1987-03-09 |
1992-12-15 |
Alza Corporation |
Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug
|
US5049387A
(en)
*
|
1987-03-09 |
1991-09-17 |
Alza Corporation |
Inducing skin tolerance to a sensitizing drug
|
IL86170A
(en)
*
|
1987-05-01 |
1992-12-01 |
Elan Transdermal Ltd |
Preparations and compositions comprising nicotine for percutaneous administration
|
HU197519B
(en)
*
|
1987-06-22 |
1989-04-28 |
Biogal Gyogyszergyar |
Process for producing medicine form capable for penetrating through epidermis and suitable for intaking the agent through epidermis by kinetics of zero-grade
|
US4820720A
(en)
*
|
1987-08-24 |
1989-04-11 |
Alza Corporation |
Transdermal drug composition with dual permeation enhancers
|
US4764379A
(en)
*
|
1987-08-24 |
1988-08-16 |
Alza Corporation |
Transdermal drug delivery device with dual permeation enhancers
|
US5059189A
(en)
*
|
1987-09-08 |
1991-10-22 |
E. R. Squibb & Sons, Inc. |
Method of preparing adhesive dressings containing a pharmaceutically active ingredient
|
US4920101A
(en)
*
|
1987-09-30 |
1990-04-24 |
Nelson Research & Development Co. |
Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
|
US4879275A
(en)
*
|
1987-09-30 |
1989-11-07 |
Nelson Research & Development Co. |
Penetration enhancers for transdermal delivery of systemic agent
|
US4839174A
(en)
*
|
1987-10-05 |
1989-06-13 |
Pharmetrix Corporation |
Novel transdermal nicotine patch
|
US4943435A
(en)
*
|
1987-10-05 |
1990-07-24 |
Pharmetrix Corporation |
Prolonged activity nicotine patch
|
US4959208A
(en)
*
|
1987-10-19 |
1990-09-25 |
Ppg Industries, Inc. |
Active agent delivery device
|
US5071645A
(en)
*
|
1987-10-19 |
1991-12-10 |
Ppg Industries, Inc. |
Process of producing an active agent delivery device
|
US5035886A
(en)
*
|
1987-10-19 |
1991-07-30 |
Ppg Industries, Inc. |
Active agent delivery device
|
US4917895A
(en)
*
|
1987-11-02 |
1990-04-17 |
Alza Corporation |
Transdermal drug delivery device
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4837027A
(en)
*
|
1987-11-09 |
1989-06-06 |
Alza Corporation |
Transdermal drug delivery device
|
US4812305A
(en)
*
|
1987-11-09 |
1989-03-14 |
Vocal Rodolfo S |
Well medicine strip
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US5068226A
(en)
*
|
1987-12-07 |
1991-11-26 |
Cyclex, Inc. |
Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
|
US4979946A
(en)
*
|
1987-12-14 |
1990-12-25 |
The Kendall Company |
Environmental absorbent dressing
|
US4906475A
(en)
*
|
1988-02-16 |
1990-03-06 |
Paco Pharmaceutical Services |
Estradiol transdermal delivery system
|
GB8804164D0
(en)
*
|
1988-02-23 |
1988-03-23 |
Tucker J M |
Bandage for administering physiologically active compound
|
GB2232892B
(en)
*
|
1988-02-23 |
1991-07-24 |
John Mark Tucker |
Occlusive body for administering a physiologically active substance
|
US5223261A
(en)
*
|
1988-02-26 |
1993-06-29 |
Riker Laboratories, Inc. |
Transdermal estradiol delivery system
|
US4885154A
(en)
*
|
1988-03-01 |
1989-12-05 |
Alza Corporation |
Method for reducing sensitization or irritation in transdermal drug delivery and means therefor
|
US4877618A
(en)
*
|
1988-03-18 |
1989-10-31 |
Reed Jr Fred D |
Transdermal drug delivery device
|
US4900552A
(en)
*
|
1988-03-30 |
1990-02-13 |
Watson Laboratories, Inc. |
Mucoadhesive buccal dosage forms
|
US4840796A
(en)
*
|
1988-04-22 |
1989-06-20 |
Dow Corning Corporation |
Block copolymer matrix for transdermal drug release
|
US4951657A
(en)
*
|
1988-04-22 |
1990-08-28 |
Dow Corning Corporation |
Heat sealable membrane for transdermal drug release
|
US4942037A
(en)
*
|
1988-06-02 |
1990-07-17 |
Merck & Co., Inc. |
Transdermal delivery systems
|
US5641504A
(en)
*
|
1988-06-09 |
1997-06-24 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monolinoleate
|
US5378730A
(en)
*
|
1988-06-09 |
1995-01-03 |
Alza Corporation |
Permeation enhancer comprising ethanol and monoglycerides
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
US5045059A
(en)
*
|
1989-02-15 |
1991-09-03 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US4985016A
(en)
*
|
1989-02-15 |
1991-01-15 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US5250028A
(en)
*
|
1989-02-15 |
1993-10-05 |
Alza Corporation |
Intravenous system for delivering a beneficial agent using permeability enhancers
|
US4969871A
(en)
*
|
1989-02-15 |
1990-11-13 |
Alza Corporation |
Intravenous system for delivering a beneficial agent
|
US5053227A
(en)
*
|
1989-03-22 |
1991-10-01 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US4973468A
(en)
*
|
1989-03-22 |
1990-11-27 |
Cygnus Research Corporation |
Skin permeation enhancer compositions
|
US5059426A
(en)
*
|
1989-03-22 |
1991-10-22 |
Cygnus Therapeutic Systems |
Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
|
US5788983A
(en)
*
|
1989-04-03 |
1998-08-04 |
Rutgers, The State University Of New Jersey |
Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5124157A
(en)
*
|
1989-08-18 |
1992-06-23 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5217718A
(en)
*
|
1989-08-18 |
1993-06-08 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5230896A
(en)
*
|
1989-10-12 |
1993-07-27 |
Warner-Lambert Company |
Transdermal nicotine delivery system
|
EP0497919B1
(en)
*
|
1989-10-23 |
1996-12-11 |
THERATECH, INC. (a Delaware Corporation) |
Iontophoresis device using a rate-controlling membrane
|
DE3939703C2
(en)
*
|
1989-12-01 |
1998-07-02 |
Boehringer Ingelheim Kg |
Improved transdermal application of pharmacologically active compounds
|
US5508038A
(en)
*
|
1990-04-16 |
1996-04-16 |
Alza Corporation |
Polyisobutylene adhesives for transdermal devices
|
US5130139A
(en)
*
|
1990-07-06 |
1992-07-14 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5160741A
(en)
*
|
1990-07-06 |
1992-11-03 |
Alza Corporation |
Reduction or prevention of skin irritation by drugs
|
US5149539A
(en)
*
|
1990-08-03 |
1992-09-22 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5120545A
(en)
*
|
1990-08-03 |
1992-06-09 |
Alza Corporation |
Reduction or prevention of sensitization to drugs
|
US5173302A
(en)
*
|
1990-09-28 |
1992-12-22 |
Medtronic, Inc. |
Hydrophilic pressure sensitive adhesive for topical administration of hydrophobic drugs
|
JPH06502419A
(en)
*
|
1990-10-29 |
1994-03-17 |
アルザ・コーポレーション |
Transdermal contraceptive preparations, methods and devices
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5198223A
(en)
*
|
1990-10-29 |
1993-03-30 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5314694A
(en)
*
|
1990-10-29 |
1994-05-24 |
Alza Corporation |
Transdermal formulations, methods and devices
|
US5320850A
(en)
*
|
1990-10-29 |
1994-06-14 |
Alza Corporation |
Transdermal delivery of the gestogen ST-1435 and devices therefor
|
US5633009A
(en)
*
|
1990-11-28 |
1997-05-27 |
Sano Corporation |
Transdermal administration of azapirones
|
US5240917A
(en)
*
|
1991-04-03 |
1993-08-31 |
Keimowitz Rudolph M |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
US5203768A
(en)
*
|
1991-07-24 |
1993-04-20 |
Alza Corporation |
Transdermal delivery device
|
US5464387A
(en)
*
|
1991-07-24 |
1995-11-07 |
Alza Corporation |
Transdermal delivery device
|
US5273756A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
|
US5234690A
(en)
*
|
1991-08-23 |
1993-08-10 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
|
US5273755A
(en)
*
|
1991-08-23 |
1993-12-28 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using a polymer-filled microporous membrane to achieve delayed onset
|
US5189986A
(en)
*
|
1991-09-23 |
1993-03-02 |
Alza Corporation |
Veterinary transdermal active agent delivery device
|
US5508039A
(en)
*
|
1991-10-18 |
1996-04-16 |
Alza Corporation |
Controlled transdermal administration of melatonin
|
US5364634A
(en)
*
|
1991-11-08 |
1994-11-15 |
Southwest Research Institute |
Controlled-release PH sensitive capsule and adhesive system and method
|
HRP921157A2
(en)
*
|
1991-12-20 |
1994-10-31 |
Lohmann Therapie Syst Lts |
Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy
|
US5268179A
(en)
*
|
1992-02-14 |
1993-12-07 |
Ciba-Geigy Corporation |
Ultrasonically sealed transdermal drug delivery systems
|
JP3786684B2
(en)
*
|
1992-05-13 |
2006-06-14 |
アルザ・コーポレーション |
Transdermal administration of oxybutynin
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
US6071896A
(en)
*
|
1992-06-16 |
2000-06-06 |
Gundersen Clinic, Ltd. |
Suppression of thromboxane levels by percutaneous administration of aspirin
|
DE4305881C1
(en)
*
|
1993-02-26 |
1994-03-03 |
Lohmann Therapie Syst Lts |
Transdermal therapeutic system for topical and systemic application of active agents - includes cpd(s) from which nitrogen oxide is released by human or animal metabolism or cpds which release nitrogen oxide in organism
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6287598B1
(en)
|
1993-05-28 |
2001-09-11 |
Alza Corporation |
Method for providing sustained antiepileptic therapy
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
ATE149349T1
(en)
*
|
1993-06-25 |
1997-03-15 |
Alza Corp |
INCORPORATING A POLY-N-VINYLAMIDE INTO A TRANSDERMAL SYSTEM
|
JPH09503997A
(en)
*
|
1993-07-08 |
1997-04-22 |
シグナス,インコーポレイテッド |
Monolithic matrix transdermal delivery system
|
US5691377A
(en)
*
|
1993-07-30 |
1997-11-25 |
University Of Maryland Eastern Shore And University Of Maryland College Park |
Use of N-methyl-aspartic acid for enhancing growth and altering body composition
|
US5747065A
(en)
*
|
1993-09-29 |
1998-05-05 |
Lee; Eun Soo |
Monoglyceride/lactate ester permeation enhancer for oxybutynin
|
JPH07157424A
(en)
*
|
1993-12-03 |
1995-06-20 |
Lintec Corp |
Gel formulation for local anesthesia
|
DE4341444C2
(en)
*
|
1993-12-04 |
1996-03-14 |
Lohmann Therapie Syst Lts |
Active substance-containing plaster and process for its production
|
US5962011A
(en)
*
|
1993-12-06 |
1999-10-05 |
Schering-Plough Healthcare Products, Inc. |
Device for delivery of dermatological ingredients
|
DE4343838C2
(en)
*
|
1993-12-22 |
1998-07-09 |
Lohmann Therapie Syst Lts |
Deuterated drug in transdermal application and process for its manufacture
|
DE4403709A1
(en)
*
|
1994-02-07 |
1995-08-10 |
Lohmann Therapie Syst Lts |
Pharmaceutical composition for systemic transdermal administration with the active ingredient morphine-6-glucuronide
|
US5536263A
(en)
*
|
1994-03-30 |
1996-07-16 |
Lectec Corporation |
Non-occulusive adhesive patch for applying medication to the skin
|
EP0755244A1
(en)
*
|
1994-04-13 |
1997-01-29 |
Novartis AG |
Temporally controlled drug delivery systems
|
US5490415A
(en)
*
|
1994-04-15 |
1996-02-13 |
Pharmetrix Corporation |
Diffusion test apparatus and method
|
US20040191314A1
(en)
*
|
1994-04-28 |
2004-09-30 |
Frank Jao |
Antiepileptic dosage form and process for protecting antiepileptic drug
|
US5498417A
(en)
*
|
1994-05-12 |
1996-03-12 |
Coating Sciences, Inc. |
Transdermal delivery of appetite suppressant drug
|
DE4421433C1
(en)
*
|
1994-06-18 |
1995-06-08 |
Lohmann Therapie Syst Lts |
Transdermal therapeutic system for treatment of, e.g., hypertension
|
AU2703795A
(en)
*
|
1994-06-23 |
1996-01-19 |
Procter & Gamble Company, The |
Treatment of nicotine craving and/or smoking withdrawal symptoms with a transdermal or transmucosal composition containing nicotine and caffeine or xanthine
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
JP3576608B2
(en)
*
|
1994-11-15 |
2004-10-13 |
日東電工株式会社 |
Patches and patch preparations
|
CA2208132A1
(en)
*
|
1994-12-21 |
1996-06-27 |
Theratech, Inc. |
Transdermal delivery system with adhesive overlay and peel seal disc
|
US6344211B1
(en)
|
1994-12-24 |
2002-02-05 |
Lts Lohmann Therapie-Systeme Gmbh |
Transdermal absorption of active substances from subcooled melts
|
DE4446600A1
(en)
|
1994-12-24 |
1996-06-27 |
Lohmann Therapie Syst Lts |
Transdermal absorption of active ingredients from supercooled melts
|
US5662928A
(en)
*
|
1995-04-21 |
1997-09-02 |
Ciba-Geigy Corporation |
Method for the prevention or removal of crystalline scopolamine in a non-aqueous matrix of a transdermal system
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
AU7286996A
(en)
*
|
1995-10-18 |
1997-05-07 |
Ciba-Geigy Ag |
Thermopile powered transdermal drug delivery device
|
US6238700B1
(en)
|
1995-12-01 |
2001-05-29 |
Alza Corporation |
Method for preventing crystal formation in a dispersion of a liquid in a matrix
|
ATE207348T1
(en)
|
1995-12-01 |
2001-11-15 |
Alza Corp |
IMPROVED METHOD FOR PREVENTING CRYSTAL FORMATION IN A DISPERSION OF A LIQUID SUBSTANCE IN A MATRIX
|
AUPN814496A0
(en)
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
US7094422B2
(en)
*
|
1996-02-19 |
2006-08-22 |
Acrux Dds Pty Ltd. |
Topical delivery of antifungal agents
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US5942243A
(en)
*
|
1996-11-12 |
1999-08-24 |
Polytherapeutics, Inc. |
Mucoadhesive compositions for administration of biologically active agents to animal tissue
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6110499A
(en)
*
|
1997-07-24 |
2000-08-29 |
Alza Corporation |
Phenytoin therapy
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
DK1140039T3
(en)
|
1998-12-18 |
2010-03-22 |
Alza Corp |
Transparent devices for percutaneous nicotine administration
|
JP5031144B2
(en)
*
|
1999-03-25 |
2012-09-19 |
メタボリックス,インコーポレイテッド |
Medical devices and medical applications of polyhydroxyalkanoate polymers
|
AU3932600A
(en)
*
|
1999-04-01 |
2000-10-23 |
Alza Corporation |
Transdermal drug delivery devices comprising a polyurethane drug reservoir
|
US7063859B1
(en)
|
1999-04-28 |
2006-06-20 |
Noven Pharmaceuticals, Inc. |
Barrier film lined backing layer composition and method for topical administration of active agents
|
US6733785B1
(en)
*
|
1999-06-11 |
2004-05-11 |
Lintec Corporation |
Moisture-sensitive preparation of percutaneous absorption type
|
GB2353219B
(en)
*
|
1999-08-16 |
2004-02-11 |
Johnson & Johnson Medical Ltd |
Easy to remove adhesive sheets
|
US6592892B1
(en)
|
1999-08-30 |
2003-07-15 |
Tepha, Inc. |
Flushable disposable polymeric products
|
AU4842100A
(en)
|
1999-12-10 |
2001-06-18 |
Teri Buseman |
Anti pruritic patch
|
DE19959913A1
(en)
*
|
1999-12-11 |
2001-06-28 |
Lohmann Therapie Syst Lts |
Transdermal system for the treatment of migraines containing acetylsalicylic acid
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US8329734B2
(en)
*
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
WO2003032983A1
(en)
*
|
2001-06-05 |
2003-04-24 |
Ronald Aung-Din |
Transdermal migraine therapy
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20100021526A1
(en)
*
|
2001-10-12 |
2010-01-28 |
Monosol Rx, Llc |
Ph modulated films for delivery of actives
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US8900498B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for manufacturing a resulting multi-layer pharmaceutical film
|
US7910641B2
(en)
*
|
2001-10-12 |
2011-03-22 |
Monosol Rx, Llc |
PH modulated films for delivery of actives
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US20070154527A1
(en)
*
|
2001-10-12 |
2007-07-05 |
Monosoirx, Llc |
Topical film compositions for delivery of actives
|
US20110033542A1
(en)
*
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
US20070281003A1
(en)
|
2001-10-12 |
2007-12-06 |
Fuisz Richard C |
Polymer-Based Films and Drug Delivery Systems Made Therefrom
|
US8900497B2
(en)
|
2001-10-12 |
2014-12-02 |
Monosol Rx, Llc |
Process for making a film having a substantially uniform distribution of components
|
US20060039958A1
(en)
*
|
2003-05-28 |
2006-02-23 |
Monosolrx, Llc. |
Multi-layer films having uniform content
|
US8765167B2
(en)
*
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7425292B2
(en)
*
|
2001-10-12 |
2008-09-16 |
Monosol Rx, Llc |
Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US7666337B2
(en)
*
|
2002-04-11 |
2010-02-23 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
US8663687B2
(en)
|
2001-10-12 |
2014-03-04 |
Monosol Rx, Llc |
Film compositions for delivery of actives
|
US8017150B2
(en)
*
|
2002-04-11 |
2011-09-13 |
Monosol Rx, Llc |
Polyethylene oxide-based films and drug delivery systems made therefrom
|
MXPA04010769A
(en)
*
|
2002-04-29 |
2005-07-05 |
Alza Corp |
Methods and dosage forms for controlled delivery of oxycodone.
|
BR0304960A
(en)
*
|
2002-05-31 |
2005-01-04 |
Alza Corp |
Dosage forms and compositions for osmotic release of varying dosages of oxycodone
|
US20060147493A1
(en)
*
|
2002-07-22 |
2006-07-06 |
Yang Robert K |
Packaging and dispensing of rapid dissolve dosage form
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
US20050191340A1
(en)
*
|
2002-08-09 |
2005-09-01 |
Gruenenthal Gmbh |
Opioid-receptor antagonists in transdermal systems having buprenorphine
|
GB0222522D0
(en)
|
2002-09-27 |
2002-11-06 |
Controlled Therapeutics Sct |
Water-swellable polymers
|
US20070237812A1
(en)
*
|
2006-04-11 |
2007-10-11 |
Tyco Healthcare Group |
Multi-layer wound dressings
|
US8100872B2
(en)
|
2002-10-23 |
2012-01-24 |
Tyco Healthcare Group Lp |
Medical dressing containing antimicrobial agent
|
US7202259B2
(en)
*
|
2002-11-18 |
2007-04-10 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
WO2004098567A2
(en)
*
|
2003-04-30 |
2004-11-18 |
Purdue Pharma L.P. |
Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
AU2004238229B2
(en)
|
2003-05-08 |
2007-07-12 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
WO2004112723A2
(en)
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Tropical therapy for the treatment of migraines, muscle sprains, muscle spasm, spasticity and related conditions
|
WO2005007195A1
(en)
*
|
2003-07-08 |
2005-01-27 |
Tepha, Inc. |
Poly-4-hydroxybutyrate matrices for sustained drug delivery
|
US20060287659A1
(en)
*
|
2003-08-22 |
2006-12-21 |
Tepha, Inc. |
Polyhydroxyalkanoate nerve regeneration devices
|
US20050065062A1
(en)
*
|
2003-09-24 |
2005-03-24 |
3M Innovative Properties Company |
Method of formulating a pharmaceutical composition
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US20050234024A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Clarke David E |
Materials and methods for the treatment of ulcerative colitis
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
DK1778305T3
(en)
*
|
2004-08-03 |
2010-10-18 |
Tepha Inc |
Non-curly polyhydroxyalkanoate sutures
|
GB0417401D0
(en)
|
2004-08-05 |
2004-09-08 |
Controlled Therapeutics Sct |
Stabilised prostaglandin composition
|
AR043476A1
(en)
*
|
2004-09-09 |
2005-08-03 |
Dvoskin Victor Oscar |
REGULATED SUBSTANCE ADMINISTRATION DEVICE FOR INSERTION IN A BODY CAVITY AND PROCEDURE FOR MANUFACTURING A SUPPORT MEDIA FOR SUCH SUBSTANCES
|
US7833208B2
(en)
*
|
2004-12-29 |
2010-11-16 |
Kimberly-Clark Worldwide, Inc. |
Multilayer absorbent article
|
ES2362221T3
(en)
*
|
2005-01-28 |
2011-06-29 |
Tepha, Inc. |
EMBOLIZATION WITH POLI-4-HYDROXIBUTIRATE PARTICLES.
|
JP2006306828A
(en)
*
|
2005-03-28 |
2006-11-09 |
Ooshin Mlp:Kk |
Sheetlike face pack cosmetic and kit for face pack cosmetic
|
US20060257461A1
(en)
|
2005-05-13 |
2006-11-16 |
Jansen Rolf R |
Multilayer galantamine delivery system with barrier against reservoir material flow
|
US8383149B2
(en)
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US9056061B2
(en)
*
|
2005-09-23 |
2015-06-16 |
Alza Corporation |
Transdermal nicotine salt delivery system
|
WO2007035942A2
(en)
*
|
2005-09-23 |
2007-03-29 |
Alza Corporation |
Transdermal risperidone delivery system
|
US8187639B2
(en)
|
2005-09-27 |
2012-05-29 |
Tissue Tech, Inc. |
Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
|
EP1933852B1
(en)
|
2005-09-27 |
2018-12-19 |
TissueTech, Inc. |
Amniotic membrane preparations and purified compositions and methods of use
|
US20090169602A1
(en)
*
|
2005-11-23 |
2009-07-02 |
Universität Zürich |
Allergy Treatment by Epicutaneous Allergen Administration
|
WO2007062266A2
(en)
|
2005-11-28 |
2007-05-31 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
US8377979B2
(en)
*
|
2005-12-05 |
2013-02-19 |
Taro Pharmaceuticals North America, Inc. |
Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
|
US20070172515A1
(en)
*
|
2006-01-20 |
2007-07-26 |
Monosolrx, Llc |
Film bandage for mucosal administration of actives
|
US20070190157A1
(en)
*
|
2006-01-20 |
2007-08-16 |
Monosoirx, Llc. |
Film lined packaging and method of making same
|
US20070179210A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Tyco Healthcare Group Lp |
Super soft foams
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
WO2007121188A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
PL2026803T3
(en)
|
2006-05-16 |
2012-05-31 |
Knopp Neurosciences Inc |
Compositions of r(+) and s(-) pramipexole and methods of using the same
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
GB0613333D0
(en)
*
|
2006-07-05 |
2006-08-16 |
Controlled Therapeutics Sct |
Hydrophilic polyurethane compositions
|
GB0613638D0
(en)
|
2006-07-08 |
2006-08-16 |
Controlled Therapeutics Sct |
Polyurethane elastomers
|
RU2444364C2
(en)
*
|
2006-07-12 |
2012-03-10 |
Контроллд Терапьютикс (Скотлэнд) Лтд. |
Drug delivery polymer with clindamycin hydrochloride
|
US20080090897A1
(en)
|
2006-08-11 |
2008-04-17 |
The Johns Hopkins University |
Compositions and methods for neuroprotectin
|
WO2008036299A2
(en)
*
|
2006-09-20 |
2008-03-27 |
Monosol Rx Llc |
Edible water-soluble film containing a foam reducing flavoring agent
|
MX347525B
(en)
|
2006-09-22 |
2017-04-27 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase.
|
ES2673046T3
(en)
*
|
2006-09-26 |
2018-06-19 |
Infectious Disease Research Institute |
Vaccine composition containing a synthetic adjuvant
|
US20090181078A1
(en)
*
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
CN101534799A
(en)
*
|
2006-09-29 |
2009-09-16 |
莫诺索尔克斯有限公司 |
Film embedded packaging and method of making same
|
GB0620685D0
(en)
|
2006-10-18 |
2006-11-29 |
Controlled Therapeutics Sct |
Bioresorbable polymers
|
EP2094358B1
(en)
|
2006-11-16 |
2012-11-07 |
e-Therapeutics plc |
Imidazoles for treating multi-drug resistant bacterial infections
|
JP2010510988A
(en)
|
2006-11-28 |
2010-04-08 |
マリナス ファーマシューティカルズ |
Nanoparticle formulation, method for producing the same and use thereof
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
WO2008103818A1
(en)
*
|
2007-02-21 |
2008-08-28 |
University Of Louisville Research Foundation |
Therapeutic cotinine compositions
|
FR2913600B1
(en)
*
|
2007-03-13 |
2011-02-25 |
Dbv Tech |
DEVICE FOR THE SKIN APPLICATION OF SUBSTANCES.
|
CA2681110A1
(en)
|
2007-03-14 |
2008-09-18 |
Knopp Neurosciences, Inc. |
Synthesis of chirally purified substituted benzothiazole diamines
|
WO2008116004A2
(en)
|
2007-03-19 |
2008-09-25 |
Vita Sciences, Llc |
Transdermal patch and method for delivery of vitamin b12
|
GB0712101D0
(en)
|
2007-06-22 |
2007-08-01 |
Therapeutics Ltd E |
Treatment of depression
|
GB0713116D0
(en)
*
|
2007-07-06 |
2007-08-15 |
Therapeutics Ltd E |
Treatment of melanoma
|
GB0714226D0
(en)
|
2007-07-20 |
2007-08-29 |
Therapeutics Ltd E |
anti-bacterial combination therapy
|
CN101854933A
(en)
|
2007-09-10 |
2010-10-06 |
钙医学公司 |
Regulate the chemical compound of intracellular Ca2+
|
AR068409A1
(en)
*
|
2007-09-14 |
2009-11-18 |
Drugtech Corp |
PHARMACEUTICAL, TRANSDERMIC COMPOSITIONS WITHOUT ALCOHOL
|
GB0719771D0
(en)
*
|
2007-10-10 |
2007-11-21 |
Therapeutics Ltd E |
Dexanabinol in combination with inhibitors of BRAF or MEK for the treatment of melanoma
|
WO2009137631A2
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that affect expression of cancer-related protein isoforms
|
WO2009137630A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Wintherix Llc |
Methods for identifying compounds that modulate wnt signaling in cancer cells
|
US20090304776A1
(en)
*
|
2008-06-06 |
2009-12-10 |
Totada Shantha |
Transmucosal delivery of therapeutic agents and methods of use thereof
|
US7883487B2
(en)
*
|
2008-06-16 |
2011-02-08 |
Shantha Totada R |
Transdermal local anesthetic patch with injection port
|
GB0811024D0
(en)
*
|
2008-06-17 |
2008-07-23 |
E Therapeutics Plc |
Sustained release treatment of depression
|
EP2296652B1
(en)
|
2008-06-30 |
2017-11-08 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy
|
US8235929B2
(en)
*
|
2008-07-15 |
2012-08-07 |
Griffin Santea B |
Method of treating pruritis
|
GB0813211D0
(en)
|
2008-07-18 |
2008-08-27 |
E Therapeutics Plc |
Antibacterial combination therapy for the treatment of gram positive bacterial infections
|
CN102186350A
(en)
*
|
2008-08-19 |
2011-09-14 |
诺普神经科学股份有限公司 |
Compositions and methods of using (r)-pramipexole
|
JP5782377B2
(en)
|
2008-08-27 |
2015-09-24 |
カルシメディカ,インク. |
Compounds that regulate intracellular calcium
|
AU2009285774B2
(en)
*
|
2008-08-28 |
2014-06-12 |
Kpr U.S., Llc |
Anti-microbial fibers and related articles and methods
|
US8715715B2
(en)
|
2008-11-03 |
2014-05-06 |
Nal Pharmaceuticals Ltd. |
Dosage form for insertion into the mouth
|
US8317762B2
(en)
*
|
2008-11-10 |
2012-11-27 |
Nurman Salim |
Skin patch for absorbing toxins from the body
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
US20100158905A1
(en)
|
2008-12-19 |
2010-06-24 |
Nuon Therapeutics, Inc. |
Combination therapy of arthritis with tranilast
|
US20100209484A1
(en)
*
|
2009-02-13 |
2010-08-19 |
Hoo-Kyun Choi |
Transdermal Triptan Delivery System
|
WO2010124296A2
(en)
|
2009-04-24 |
2010-10-28 |
Tissuetech, Inc. |
Compositions containing hc•ha complex and methods of use thereof
|
CN105131051B
(en)
|
2009-06-05 |
2020-07-10 |
传染性疾病研究院 |
Synthetic glucopyranosyl lipid adjuvants
|
AU2010262970A1
(en)
*
|
2009-06-19 |
2012-01-12 |
Knopp Neurosciences, Inc. |
Compositions and methods for treating amyotrophic lateral sclerosis
|
US8475832B2
(en)
*
|
2009-08-07 |
2013-07-02 |
Rb Pharmaceuticals Limited |
Sublingual and buccal film compositions
|
GB0915877D0
(en)
|
2009-09-10 |
2009-10-14 |
E Therapeutics Plc |
Cancer cell apoptosis
|
US7718662B1
(en)
|
2009-10-12 |
2010-05-18 |
Pharmacyclics, Inc. |
Pyrazolo-pyrimidine inhibitors of bruton's tyrosine kinase
|
DE102009056746A1
(en)
*
|
2009-12-04 |
2011-06-09 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal therapeutic system for the administration of peptides
|
EP2534145A4
(en)
|
2010-02-08 |
2013-09-11 |
Kinagen Inc |
Therapeutic methods and compositions involving allosteric kinase inhibition
|
JP6065183B2
(en)
|
2010-03-24 |
2017-01-25 |
アミテック セラピューティック ソリューションズ,インク. |
Heterocyclic compounds useful for kinase inhibition
|
KR20130073893A
(en)
|
2010-04-13 |
2013-07-03 |
나지브 바불 |
Dermal pharmaceutical compositions of 1-methyl-2'-6'-pipecoloxylidide and method of use
|
ES2602475T3
(en)
|
2010-04-15 |
2017-02-21 |
Tracon Pharmaceuticals, Inc. |
Enhancement of anticancer activity by combination therapy with BER inhibitors
|
WO2011139489A2
(en)
|
2010-04-27 |
2011-11-10 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
US8754219B2
(en)
|
2010-04-27 |
2014-06-17 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
WO2011143152A2
(en)
|
2010-05-11 |
2011-11-17 |
Questcor Pharmaceuticals |
Acth for treatment of amyotrophic lateral sclerosis
|
EP2575818A4
(en)
|
2010-06-03 |
2013-11-06 |
Pharmacyclics Inc |
The use of inhibitors of bruton's tyrosine kinase (btk)
|
WO2011156711A1
(en)
|
2010-06-10 |
2011-12-15 |
Schobel Alexander M |
Nanoparticle film delivery systems
|
WO2012027710A2
(en)
|
2010-08-27 |
2012-03-01 |
Calcimedica Inc. |
Compounds that modulate intracellular calcium
|
GB201016995D0
(en)
|
2010-10-08 |
2010-11-24 |
Univ Dundee |
Cancer targets
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
US8796416B1
(en)
|
2010-10-25 |
2014-08-05 |
Questcor Pharmaceuticals, Inc |
ACTH prophylactic treatment of renal disorders
|
AU2012204164A1
(en)
|
2011-01-07 |
2013-07-25 |
Allergan, Inc. |
Melanin modification compositions and methods of use
|
CN106390128B
(en)
|
2011-01-10 |
2022-07-08 |
伊沃恩有限公司 |
Use of beta-adrenergic inverse agonists for smoking cessation
|
GB201101793D0
(en)
|
2011-02-02 |
2011-03-16 |
Univ Edinburgh |
Weight related disorders
|
EA027236B1
(en)
|
2011-04-08 |
2017-07-31 |
Иммьюн Дизайн Корп. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
WO2012149486A1
(en)
|
2011-04-28 |
2012-11-01 |
Tissuetech, Inc. |
Methods of modulating bone remodeling
|
ES2822301T3
(en)
|
2011-06-10 |
2021-04-30 |
Tissuetech Inc |
Fetal Support Tissue Processing Methods
|
EP2768499A4
(en)
|
2011-10-17 |
2015-08-26 |
Univ Vanderbilt |
Indomethacin analogs for the treatment of castrate-resistant prostate cancer
|
CA2795586A1
(en)
|
2011-11-15 |
2013-05-15 |
Golden Biotechnology Corporation |
Methods and compositions for treatment, modification and management of bone cancer pain
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
US8377946B1
(en)
|
2011-12-30 |
2013-02-19 |
Pharmacyclics, Inc. |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors
|
US20130172424A1
(en)
|
2011-12-30 |
2013-07-04 |
Golden Biotechnology Corporation |
Methods and compositions for treating diabetes
|
HUE044841T2
(en)
|
2012-02-07 |
2019-11-28 |
Infectious Disease Res Inst |
Improved adjuvant formulations comprising tlr4 agonists and methods of using the same
|
FR2987264A1
(en)
|
2012-02-23 |
2013-08-30 |
Golden Biotechnology Corp |
METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER METASTASES
|
US10905656B2
(en)
|
2012-03-26 |
2021-02-02 |
Golden Biotechnology Corporation |
Methods and compositions for treating arteriosclerotic vascular diseases
|
GB201207305D0
(en)
|
2012-04-26 |
2012-06-13 |
E Therapeutics Plc |
Therapy
|
GB201207907D0
(en)
|
2012-05-04 |
2012-06-20 |
E Therapeutics Plc |
Treatment of depression
|
US9895435B2
(en)
|
2012-05-16 |
2018-02-20 |
Immune Design Corp. |
Vaccines for HSV-2
|
EP2872181B1
(en)
|
2012-07-11 |
2020-11-18 |
Tissuetech, Inc. |
Compositions containing hc-ha/ptx3 complexes and methods of use thereof
|
US9512116B2
(en)
|
2012-10-12 |
2016-12-06 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
MX2015006337A
(en)
|
2012-11-21 |
2015-09-07 |
Golden Biotechnology Corp |
Methods and compositions for treating neurodegenerative diseases.
|
WO2014110491A1
(en)
|
2013-01-11 |
2014-07-17 |
Theratrophix Llc |
Prodrugs of treprostinil
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
TWI597061B
(en)
|
2013-02-20 |
2017-09-01 |
國鼎生物科技股份有限公司 |
Methods and compositions for treating leukemia
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
WO2014140925A2
(en)
|
2013-03-10 |
2014-09-18 |
Peritech Pharma Ltd. |
Topical compositions and methods of treatment of topical disorders
|
WO2014153221A2
(en)
|
2013-03-14 |
2014-09-25 |
Questcor Pharmaceuticals, Inc. |
Acth for treatment of acute respiratory distress syndrome
|
AU2014253791B2
(en)
|
2013-04-18 |
2019-05-02 |
Immune Design Corp. |
GLA monotherapy for use in cancer treatment
|
EP2999444A4
(en)
|
2013-05-20 |
2016-10-12 |
Mylan Inc |
Transdermal extended dosing of pramipexole for neurological disorders
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
ES2858500T3
(en)
|
2013-07-12 |
2021-09-30 |
Knopp Biosciences Llc |
Treatment of elevated levels of eosinophils and / or basophils
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
AU2014306597B2
(en)
|
2013-08-13 |
2018-05-17 |
Knopp Biosciences Llc |
Compositions and methods for treating chronic urticaria
|
US9611263B2
(en)
|
2013-10-08 |
2017-04-04 |
Calcimedica, Inc. |
Compounds that modulate intracellular calcium
|
AU2014360446A1
(en)
|
2013-12-05 |
2016-06-09 |
Pharmacyclics, Llc |
Inhibitors of Bruton's tyrosine kinase
|
MA39228A1
(en)
|
2014-01-21 |
2017-06-30 |
Immune Design Corp |
Compositions for use in treating allergic conditions
|
AU2015213678C1
(en)
|
2014-02-10 |
2019-03-21 |
Respivant Sciences Gmbh |
Mast cell stabilizers treatment for systemic disorders
|
CN106535889A
(en)
|
2014-02-10 |
2017-03-22 |
帕塔拉制药有限责任公司 |
Mast cell stabilizers for lung disease treatment
|
CN106414415A
(en)
|
2014-03-14 |
2017-02-15 |
北卡罗来纳大学教堂山分校 |
Small molecules for inhibiting male fertility
|
EP3134418A4
(en)
|
2014-04-23 |
2018-01-03 |
The Research Foundation for The State University of New York |
A rapid and efficient bioorthogonal ligation reaction and boron-containing heterocycles useful in conjuction therewith
|
TW201603818A
(en)
|
2014-06-03 |
2016-02-01 |
組織科技股份有限公司 |
Compositions and methods
|
EP3828160A1
(en)
|
2014-07-16 |
2021-06-02 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
CA2958747C
(en)
|
2014-08-15 |
2022-08-16 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
US9839644B2
(en)
|
2014-09-09 |
2017-12-12 |
ARKAY Therapeutics, LLC |
Formulations and methods for treatment of metabolic syndrome
|
US9359316B1
(en)
|
2014-11-25 |
2016-06-07 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
EP3230500A1
(en)
|
2014-12-11 |
2017-10-18 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
US10227333B2
(en)
|
2015-02-11 |
2019-03-12 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
TW201642914A
(en)
|
2015-02-23 |
2016-12-16 |
組織科技股份有限公司 |
Apparatuses and methods for treating ophthalmic diseases and disorders
|
CN107530304A
(en)
|
2015-02-27 |
2018-01-02 |
科泰纳制药公司 |
The suppression of OLIG2 activity
|
JP2018507262A
(en)
|
2015-03-02 |
2018-03-15 |
アフギン ファーマ, エルエルシーAfgin Pharma, Llc |
Localized local nerve action therapy using cannabinoids
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
TWI720984B
(en)
|
2015-05-20 |
2021-03-11 |
美商帝聖工業公司 |
Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
US20170014417A1
(en)
|
2015-07-14 |
2017-01-19 |
Lipp Life Sciences Llc |
Pharmaceutical administration system for the transdermal application of vardenafil
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
WO2017027402A1
(en)
|
2015-08-07 |
2017-02-16 |
Patara Pharma, LLC |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
MA45973A
(en)
|
2015-08-31 |
2019-06-26 |
Pharmacyclics Llc |
BTK INHIBITOR COMBINATIONS FOR THE TREATMENT OF MULTIPLE MYELOMA
|
WO2017068349A1
(en)
|
2015-10-23 |
2017-04-27 |
E-Therapeutics Plc |
Cannabinoid for use in immunotherapy
|
TW201733600A
(en)
|
2016-01-29 |
2017-10-01 |
帝聖工業公司 |
Fetal support tissue products and methods of use
|
US10851123B2
(en)
|
2016-02-23 |
2020-12-01 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic TRPV1 agonists
|
US11191737B2
(en)
|
2016-05-05 |
2021-12-07 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
ES2910787T3
(en)
|
2016-05-12 |
2022-05-13 |
Univ Michigan Regents |
ASH1L inhibitors and methods of treatment with them
|
CA3023672A1
(en)
|
2016-05-16 |
2017-11-23 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
KR102392974B1
(en)
|
2016-05-16 |
2022-05-02 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
Formulations containing TLR agonists and methods of use
|
CA3025268A1
(en)
|
2016-05-25 |
2017-11-30 |
Concentric Analgesics, Inc. |
Prodrugs of phenolic trpv1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia
|
WO2017205766A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205769A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
WO2017205762A1
(en)
|
2016-05-27 |
2017-11-30 |
Pharmacyclics Llc |
Inhibitors of interleukin-1 receptor-associated kinase
|
JP7140684B2
(en)
|
2016-06-01 |
2022-09-21 |
アクセス ツー アドバンスト ヘルス インスティチュート |
Nano Alum Particles Containing Sizing Agent
|
US10773008B2
(en)
*
|
2016-08-08 |
2020-09-15 |
Universiti Brunei Darussalam |
Medicated patch for preventing exit site infections during peritoneal dialysis
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
US11242323B2
(en)
|
2016-08-26 |
2022-02-08 |
Curtana Pharmaceuticals, Inc. |
Inhibition of OLIG2 activity
|
CA3035528A1
(en)
|
2016-08-31 |
2018-03-08 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
|
AU2017339366A1
(en)
|
2016-10-07 |
2019-04-11 |
Respivant Sciences Gmbh |
Cromolyn compositions for treatment of pulmonary fibrosis
|
CN110381930A
(en)
|
2016-12-05 |
2019-10-25 |
康赛制药公司 |
The percutaneous and transdermal administration of treprostinil and its salt
|
WO2018231706A1
(en)
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
EP3706737A4
(en)
|
2017-11-10 |
2021-10-20 |
The Regents of the University of Michigan |
Ash1l inhibitors and methods of treatment therewith
|
CN112040947A
(en)
|
2017-12-07 |
2020-12-04 |
密歇根大学董事会 |
NSD family inhibitors and methods of treatment therewith
|
EP4155293A1
(en)
|
2018-06-07 |
2023-03-29 |
The Regents of The University of Michigan |
Prc1 inhibitors and methods of treatment therewith
|
TW202019887A
(en)
|
2018-07-27 |
2020-06-01 |
美商同心止痛劑股份有限公司 |
Pegylated prodrugs of phenolic trpv1 agonists
|
CA3125350A1
(en)
|
2018-12-31 |
2020-07-09 |
Biomea Fusion, Llc |
Irreversible inhibitors of menin-mll interaction
|
CA3133093A1
(en)
|
2019-03-15 |
2020-09-24 |
Unicycive Therapeutics, Inc. |
Nicorandil derivatives
|
JP2023533982A
(en)
|
2020-07-10 |
2023-08-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
GAS41 inhibitor and method of use thereof
|
CA3202151A1
(en)
|
2020-12-16 |
2022-06-23 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin-mll interaction
|
TW202320796A
(en)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
Covalent inhibitors of menin-mll interaction for diabetes mellitus
|
WO2023027966A1
(en)
|
2021-08-24 |
2023-03-02 |
Biomea Fusion, Inc. |
Pyrazine compounds as irreversible inhibitors of flt3
|
WO2023039240A1
(en)
|
2021-09-13 |
2023-03-16 |
Biomea Fusion, Inc. |
IRREVERSIBLE INHIBITORS OF KRas
|
WO2023086341A1
(en)
|
2021-11-09 |
2023-05-19 |
Biomea Fusion, Inc. |
Inhibitors of kras
|
WO2023119230A1
(en)
|
2021-12-22 |
2023-06-29 |
L'oreal |
Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use
|
KR20240128987A
(en)
|
2021-12-30 |
2024-08-27 |
바이오메아 퓨전, 인크. |
Pyrazine compounds as inhibitors of FLT3
|
WO2023235618A1
(en)
|
2022-06-03 |
2023-12-07 |
Biomea Fusion, Inc. |
Fused pyrimidine compounds as inhibitors of menin
|